Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant

Virology

Volumn 244, Issue 2, 1998, Pages 552-562

  Das, Atze T ^a   Van Dam, Alje P ^a   Klaver, Bep ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RNA TRANSLATION; START CODON; TRANSLATION INITIATION; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032503234     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9124     Document Type: Article

References (38)

1. Auersperg N. Long-term cultivation of hypodiploid human tumor cells. J. Natl. Cancer Inst. 32:1964;135-163.
2. Belsham G. J., Sonenberg N. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60:1996;499-511.
3. Berkhout B. Structural features in TAR RNA of human and simian immunodeficiency viruses: A phylogenetic analysis. Nucleic Acids Res. 20:1992;27-31.
4. Berkhout B. Structure and function of the Human Immunodeficiency Virus leader RNA. Progr. Nucleic Acids Res. Mol. Biol. 54:1996;1-34.
5. Berkhout B., Klaver B., Das A. T. A conserved hairpin structure predicted for the poly(A) signal of human and simian immunodeficiency viruses. Virology. 207:1995;276-281.
6. Berkhout B., Klaver B. In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res. 21:1993;5020-5024.
7. Berkhout B., Klaver B. Revertants and pseudo-revertants of human immunodeficiency virus type 1 viruses mutated in the long terminal repeat promoter region. J. Gen. Virol. 76:1995;845-853.
8. Berkhout B., van Wamel J. L. B. Role of the DIS hairpin in replication of human immunodeficiency virus type 1. J. Virol. 70:1996;6723-6732.
9. Berlioz C., Torrent C., Darlix J.-L. An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic vectors. J. Virol. 69:1995;6400-6407.
10. Berlioz C., Darlix J.-L. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J. Virol. 69:1995;2214-2222.
11. Bieth E., Gabus C., Darlix J.-L. A study of the dimer formation of Rous sarcoma virus RNA and its effect on viral protein synthesis in vitro. Nucleic Acids Res. 18:1990;119-127.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
13. Das A. T., Klaver B., Berkhout B. Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J. Virol. 69:1995;3090-3097.
14. Das A. T., Salvadó J., Boon L., Biharie G., Moorman A. F. M., Lamers W. H. Regulation of glutamate dehydrogenase expression in the developing rat liver: Control at different levels in the prenatal period. Eur. J. Biochem. 235:1996;677-682.
15. Das A. T., Klaver B., Klasens B. I. F., van Wamel J. L. B., Berkhout B. A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J. Virol. 71:1997;2346-2356.
16. de Ronde A., Klaver B., Keulen W., Smit L., Goudsmit J. Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology. 188:1992;391-395.
17. Edery I. R., Petryshyn R., Sonenberg N. Activation of double-stranded RNA dependent kinase (dsI) by the TAR region of HIV-1 mRNA: a novel translational control mechanism. Cell. 56:1989;303-312.
18. Fujita K., Silver J., Peden K. Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1. J. Virol. 66:1992;4445-4451.
19. Futterer J., Kiss-Laszio Z., Hohn T. Nonlinear ribosome migration on cauliflower mosaic virus 35S RNA. Cell. 73:1993;789-802.
20. Geballe A. P., Gray M. K. Variable inhibition of cell-free translation by HIV-1 transcript leader sequences. Nucleic Acids Res. 20:1992;4291-4297.
21. Gibbs J. S., Regier D. A., Desrosiers R. C. Construction and in vitro properties of HIV-1 mutants with deletions in "nonessential" genes. AIDS Res. Hum. Retroviruses. 10:1994;343-350.
22. Harrowe G., Cheng-Mayer C. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology. 210:1995;490-494.
23. Honda M., Brown E. A., Lemon S. M. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA. 2:1996;955-968.
24. Keulen W., Boucher C., Berkhout B. Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res. 31:1996;45-57.
25. Klaver B., Berkhout B. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 13:1994;2650-2659.
26. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 44:1986a;283-292.
27. Kozak M. Influence of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA. 83:1986b;2850-2854.
28. Kozak M. Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell Biol. 9:1989a;5134-5142.
29. Kozak M. The scanning model for translation: An update. J. Cell Biol. 108:1989b;229-241.
30. Kunkel, T. A. Roberts, J. D. Zakour, R. A. 1987, Methods in Enzymology, 367, 382, Academic Press, San Diego.
31. Miele G., Mouland A., Harrison G. P., Cohen E., Lever A. M. The human immunodeficiency virus type 1 5′ packaging signal structure affects translation but does not function as an internal ribosome entry site structure. J. Virol. 70:1996;944-951.
32. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
33. Myers, G. Korber, B. Hahn, B. H. Jeang, K.-T. Mellors, J. H. McCutchan, F. E. Henderson, L. E. Pavlakis, G. N. 1995, Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico.
34. Parkin N. T., Cohen E. A., Darveau A., Rosen C., Haseltine W., Sonenberg N. Mutational analysis of the 5′ noncoding region of human immunodeficiency virus type 1: Effects of secondary structure. EMBO J. 7:1988;2831-2837.
35. LAIMALELI. Virology. 185:1991;661-672.
36. SenGupta D. N., Berkhout B., Gatignol A., Zhou A. M., Silverman R. H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 87:1990;7492-7496.
37. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:1994;115-123.
38. Vagner S., Waysbort A., Marenda M., Gensac M.-C., Amalric F., Prats A.-C. Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor. J. Biol. Chem. 270:1995;20376-20383.